Teva Pharmaceutical Industries (TEVA) Operating Leases (2019 - 2026)
Teva Pharmaceutical Industries' Operating Leases was $282 million in Q2 2026, down 4.7% from $296 million a year earlier but up 0.7% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Teva Pharmaceutical Industries came in at $288 million, down 2.7% from FY2024.
- Operating Leases has now declined for five consecutive years, with a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In earlier years, Operating Leases was $296 million in FY2024 (-7.5%), $320 million in FY2023 (-8.3%), $349 million in FY2022 (-16.1%) and $416 million in FY2021 (-13.2%).
- Quarterly Operating Leases has moved between $280 million (Q1 2026) and $425 million (Q3 2021) over five years.
- Compared with a year earlier, Operating Leases has declined for four straight quarters, with an average decline of 3.4% over the last eight quarters.
- The best year-over-year quarter for Operating Leases over five years was Q2 2025 (growth of 5.3%); the worst was Q2 2024 (a decline of 16.9%).
- Per Business Quant data, TEVA's Operating Leases in the three quarters before Q2 2026 was $280 million (Q1 2026), $288 million (Q4 2025) and $283 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 282.00 Mn |
| Mar 31, 2026 | 280.00 Mn |
| Dec 31, 2025 | 288.00 Mn |
| Sep 30, 2025 | 283.00 Mn |
| Jun 30, 2025 | 296.00 Mn |
| Mar 31, 2025 | 288.00 Mn |
| Dec 31, 2024 | 296.00 Mn |
| Sep 30, 2024 | 295.00 Mn |
| Jun 30, 2024 | 281.00 Mn |
| Mar 31, 2024 | 294.00 Mn |
| Dec 31, 2023 | 320.00 Mn |
| Sep 30, 2023 | 324.00 Mn |
| Jun 30, 2023 | 338.00 Mn |
| Mar 31, 2023 | 345.00 Mn |
| Dec 31, 2022 | 349.00 Mn |
| Sep 30, 2022 | 354.00 Mn |
| Jun 30, 2022 | 371.00 Mn |
| Mar 31, 2022 | 393.00 Mn |
| Dec 31, 2021 | 416.00 Mn |
| Sep 30, 2021 | 425.00 Mn |
API Access
Teva Pharmaceutical Industries Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();